Lakefront Biotherapeutics (GLPGF) Interest & Investment Income (2017 - 2019)
Lakefront Biotherapeutics' (GLPGF) quarterly Interest & Investment Income came in at -$1.5 million in Q2 2019, down 119.54% year-over-year from $7.8 million in Q2 2018, and down 119.05% quarter-over-quarter from $8.0 million in Q1 2019.
Powered by 
Analysis
Lakefront Biotherapeutics (GLPGF) Interest & Investment Income (2017 - 2019) Analysis & Trends
Lakefront Biotherapeutics (GLPGF) has reported Interest & Investment Income for 3 consecutive years, with -$1.5 million the latest figure, recorded in Q2 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.88 Bn | 197.89 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 181.55 Bn | 178.37 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.31 Bn | 124.45 Bn | 2.84 Bn | 120.60 Mn |
| 4 | Regeneron Pharmaceuticals | 82.51 Bn | 74.52 Bn | 3.93 Bn | -48.00 Mn |
| 5 | Argenx Se | 61.54 Bn | 56.36 Bn | 1.37 Bn | 48.00 Mn |
| 6 | Moderna | 54.69 Bn | 49.55 Bn | 52.00 Mn | 67.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.07 Bn | 30.76 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Biogen | 31.41 Bn | 30.12 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.10 Bn | 30.10 Bn | 1.16 Mn | 36.92 Mn |
| 10 | Lakefront Biotherapeutics | 1.73 Bn | 1.73 Bn | 3.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2019 | -1.52 Mn |
| Mar 31, 2019 | 7.96 Mn |
| Sep 30, 2018 | 2.98 Mn |
| Jun 30, 2018 | 7.76 Mn |
| Mar 31, 2018 | 1.98 Mn |
| Sep 30, 2017 | 1.58 Mn |
| Jun 30, 2017 | 1.57 Mn |
| Mar 31, 2017 | 952,473.77 |